Would the cost-cutting measures for U.S. prescription drugs proposed by the Trump administration on Monday hurt the biotech ...

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international alliances.

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

BioSpace examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made ...

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc. is a better investment based on ...

President Trump unveiled his plan to dramatically overhaul the way the U.S. pays for drugs. Pharma investors didn't seem to ...

We hoped industry layoffs would relent in ... Story Feb. 6 - X4 Pharmaceuticals: The rare disease biotech is laying off 43 employees—equivalent to 30% of the company’s total staffers—along ...

President Trump announced a plan to reduce prescription drug prices by implementing a most-favored-nation policy with the ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering.

The Pharma AI Council officially launched today, establishing a new force to drive innovation and the responsible application ...

In an era of rapid digital transformation, the pharmaceutical industry is increasingly leveraging advanced integration technologies to streamline operations and enhance efficiency. Rishi Nareshbhai ...